New report sheds light on medicine shortages in Northern Ireland following Brexit
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
British Generic Manufacturers Association
Informa Pharma Intelligence
database and aggregator
Copyright of cited content as per its respective owners | Copyright (of the database) - BrexitDB.com